Welcome to our dedicated page for Balchem news (Ticker: BCPC), a resource for investors and traders seeking the latest updates and insights on Balchem stock.
Balchem Corporation (NASDAQ: BCPC) is a global specialty ingredient manufacturer for health and nutrition markets, and its news flow reflects this focus. Company press releases highlight the development, manufacture and marketing of specialty ingredients that improve and enhance the health and well-being of life on the planet, as well as financial and corporate updates relevant to investors and industry observers.
Visitors to this BCPC news page can review Balchem’s announcements on quarterly financial results, dividend declarations and participation in investor conferences. Recent releases have reported segment-level performance for its Human Nutrition & Health, Animal Nutrition & Health and Specialty Products segments, along with measures such as net sales, earnings from operations, adjusted EBITDA and free cash flow, as described in accompanying Form 8-K filings.
Balchem also issues news related to regulatory and trade developments that affect its markets. For example, the company joined another EU producer in welcoming European Union anti-dumping duties on choline chloride imports from China, emphasizing the importance of fair trade for the EU food and feed supply chain and for maintaining a healthy domestic choline chloride industry.
In addition, Balchem regularly announces its participation in conferences hosted by firms such as CJS Securities, Baird, H.C. Wainwright, Wells Fargo and others, where its leadership presents to the investment community. These updates provide insight into how the company communicates its strategy and segment performance to shareholders and analysts. Investors and researchers can use this news stream to follow Balchem’s financial reporting, capital allocation decisions such as dividends, and its commentary on market and regulatory conditions affecting its human nutrition, animal nutrition and specialty products businesses.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Balchem Corporation (NASDAQ: BCPC) has announced a conference call scheduled for April 28, 2023, at 11:00 AM ET to discuss its first-quarter results. Results will be publicly released before the market opens on the same day. The call will be led by CEO Ted Harris and CFO Martin Bengtsson, and will be available for replay until May 12, 2023. Interested parties can join the call by dialing 1-877-407-8289 or 1-201-689-8341. Balchem operates across three segments: Human Nutrition & Health, Animal Nutrition & Health, and Specialty Products, focusing on developing specialty ingredients to enhance health and well-being across various industries worldwide.
Balchem Corporation (NASDAQ: BCPC) reported impressive fourth quarter financial results for 2022, with net sales of $232.5 million, up 9.1% from $213.1 million in Q4 2021. However, net earnings decreased to $21.4 million from $24.9 million, although adjusted net earnings rose to $30.3 million from $27.8 million. For the full year, net sales increased 17.9% to a record $942.4 million, while net earnings rose 9.6% to $105.4 million. The company achieved record sales across all three segments: Human Nutrition & Health, Animal Nutrition & Health, and Specialty Products. Balchem also maintained a strong cash flow and continues to focus on strategic growth initiatives.